08/05/2019
4:49 PM | Crispr Therapeutics (Issuer)
Ho Tony W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities |  |
07/29/2019
3:32 PM | Crispr Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/29/2019
3:20 PM | Crispr Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/29/2019
3:05 PM | Crispr Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/12/2019
3:13 PM | Crispr Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2019
3:10 PM | Crispr Therapeutics (Issuer)
Novak Rodger (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2019
1:28 PM | Crispr Therapeutics (Subject)
Versant Venture Capital IV, L.P. (Filed by)
| Form SC 13D/A
| |
06/26/2019
7:45 AM | Crispr Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/19/2019
3:15 PM | Crispr Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2019
7:49 PM | Crispr Therapeutics (Issuer)
High Katherine A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2019
7:42 PM | Crispr Therapeutics (Issuer)
High Katherine A (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/13/2019
4:07 PM | Behbahani Ali (Reporting)
Crispr Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2019
4:05 PM | Bolzon Bradley J PhD (Reporting)
Crispr Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2019
4:05 PM | Crispr Therapeutics (Issuer)
Greene John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2019
4:04 PM | CAGNONI PABLO J (Reporting)
Crispr Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2019
4:04 PM | Crispr Therapeutics (Issuer)
George Simeon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2019
3:44 PM | Crispr Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2019
3:16 PM | Crispr Therapeutics (Issuer)
Novak Rodger (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2019
3:04 PM | Crispr Therapeutics (Subject)
VERTEX PHARMACEUTICALS INC / MA (Filed by)
| Form SC 13D/A
| |
06/06/2019
4:20 PM | Crispr Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2019
3:25 PM | Crispr Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2019
3:07 PM | Crispr Therapeutics (Filer)
| Form DEFA14A
| |
04/29/2019
3:05 PM | Crispr Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2019
6:27 AM | Crispr Therapeutics (Filer)
| Form PRER14A
| |
04/23/2019
1:34 PM | Crispr Therapeutics (Filer)
| Form PRER14A
| |
04/09/2019
3:15 PM | Crispr Therapeutics (Filer)
| Form PRE 14A
| |
03/07/2019
3:17 PM | Crispr Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2019
3:14 PM | Crispr Therapeutics (Issuer)
TOMSICEK MICHAEL JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2019
3:14 PM | Crispr Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2019
3:12 PM | Crispr Therapeutics (Issuer)
Ho Tony W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2019
3:11 PM | Crispr Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2019
3:10 PM | Crispr Therapeutics (Issuer)
Novak Rodger (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2019
4:32 PM | Crispr Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/25/2019
7:16 AM | Crispr Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/25/2019
7:15 AM | Crispr Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2019
9:21 AM | Crispr Therapeutics (Subject)
New Enterprise Associates 15, L.P. (Filed by)
| Form SC 13G/A
| |
01/18/2019
3:32 PM | Crispr Therapeutics (Issuer)
EMSTER KURT VON (Reporting)
| Form 4/A
| |
01/10/2019
3:09 PM | Crispr Therapeutics (Issuer)
Novak Rodger (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2019
3:32 PM | Crispr Therapeutics (Issuer)
Klein Lawrence Otto (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2018
3:34 PM | Crispr Therapeutics (Issuer)
Vertex Pharmaceuticals Ltd (0001761216) (Reporting)
VERTEX PHARMACEUTICALS INC / MA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2018
3:30 PM | Crispr Therapeutics (Subject)
VERTEX PHARMACEUTICALS INC / MA (Filed by)
| Form SC 13D/A
| |
12/26/2018
3:35 PM | Crispr Therapeutics (Issuer)
Vertex Pharmaceuticals Ltd (0001761216) (Reporting)
VERTEX PHARMACEUTICALS INC / MA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2018
3:33 PM | Crispr Therapeutics (Subject)
VERTEX PHARMACEUTICALS INC / MA (Filed by)
| Form SC 13D/A
| |
12/21/2018
4:16 PM | Crispr Therapeutics (Issuer)
Vertex Pharmaceuticals Ltd (0001761216) (Reporting)
VERTEX PHARMACEUTICALS INC / MA (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/21/2018
4:14 PM | Crispr Therapeutics (Subject)
VERTEX PHARMACEUTICALS INC / MA (Filed by)
| Form SC 13D
| |
12/19/2018
3:22 PM | Crispr Therapeutics (Issuer)
EMSTER KURT VON (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2018
3:29 PM | Crispr Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2018
4:29 PM | Crispr Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2018
10:08 AM | Crispr Therapeutics (Filer)
| Form CT ORDER
| |
11/07/2018
4:22 PM | Crispr Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2018
4:25 PM | Crispr Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/24/2018
7:23 PM | Crispr Therapeutics (Filer)
| Form 424B5
| |
09/24/2018
4:27 PM | Crispr Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/21/2018
3:16 PM | Crispr Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/21/2018
3:10 PM | Crispr Therapeutics (Filer)
| Form 424B5
| |
09/19/2018
3:21 PM | Crispr Therapeutics (Filer)
| Form 424B5
| |
09/19/2018
3:02 PM | Crispr Therapeutics (Filer)
| Form S-3ASR
| |
09/17/2018
7:13 AM | Crispr Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2018
8:00 AM | Crispr Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/04/2018
5:33 PM | Crispr Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/31/2018
3:13 PM | Crispr Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/31/2018
3:03 PM | Crispr Therapeutics (Filer)
| Form 424B5
| |
08/07/2018
4:10 PM | Crispr Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/03/2018
4:43 PM | Crispr Therapeutics (Issuer)
Ho Tony W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2018
5:25 PM | CAGNONI PABLO J (Reporting)
Crispr Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/19/2018
3:55 PM | Crispr Therapeutics (Issuer)
George Simeon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2018
8:46 PM | Behbahani Ali (Reporting)
Crispr Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2018
8:41 PM | Crispr Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2018
8:40 PM | Bolzon Bradley J PhD (Reporting)
Crispr Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2018
8:39 PM | Crispr Therapeutics (Issuer)
Woiwode Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2018
8:38 PM | Crispr Therapeutics (Issuer)
Ho Tony W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2018
8:37 PM | Crispr Therapeutics (Issuer)
TOMSICEK MICHAEL JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2018
8:36 PM | Crispr Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2018
8:35 PM | CAGNONI PABLO J (Reporting)
Crispr Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2018
6:23 PM | Crispr Therapeutics (Issuer)
EMSTER KURT VON (Reporting)
| Form 4/A
| |
06/07/2018
3:36 PM | Crispr Therapeutics (Issuer)
EMSTER KURT VON (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2018
7:20 PM | Crispr Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2018
4:05 PM | Crispr Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2018
3:37 PM | Crispr Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/21/2018
3:54 PM | Crispr Therapeutics (Issuer)
Novak Rodger (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2018
4:15 PM | Bolzon Bradley J PhD (Reporting)
Crispr Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2018
4:11 PM | Crispr Therapeutics (Issuer)
Woiwode Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2018
7:04 PM | Crispr Therapeutics (Issuer)
EMSTER KURT VON (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2018
4:15 PM | Crispr Therapeutics (Issuer)
Woiwode Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2018
4:14 PM | Bolzon Bradley J PhD (Reporting)
Crispr Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2018
6:43 AM | Crispr Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2018
6:26 AM | Crispr Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/02/2018
5:00 PM | Crispr Therapeutics (Issuer)
Woiwode Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2018
5:00 PM | Bolzon Bradley J PhD (Reporting)
Crispr Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2018
7:58 PM | Bolzon Bradley J PhD (Reporting)
Crispr Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2018
7:57 PM | Crispr Therapeutics (Issuer)
Woiwode Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/26/2018
4:01 PM | Crispr Therapeutics (Issuer)
Woiwode Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/26/2018
3:57 PM | Bolzon Bradley J PhD (Reporting)
Crispr Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/26/2018
3:44 PM | Crispr Therapeutics (Issuer)
Versant Affiliates Fund V, L.P. (Reporting)
Versant Ophthalmic Affiliates I, L.P. (Reporting)
Versant Venture Capital V , LP (0001612235) (Reporting)
Versant Venture Capital V, L.P. (Reporting)
Versant Ventures V, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/24/2018
6:44 PM | Crispr Therapeutics (Issuer)
Versant Affiliates Fund V, L.P. (Reporting)
Versant Ophthalmic Affiliates I, L.P. (Reporting)
Versant Side Fund IV, L.P. (Reporting)
Versant Venture Capital IV, L.P. (Reporting)
Versant Venture Capital V , LP (0001612235) (Reporting)
Versant Venture Capital V, L.P. (Reporting)
Versant Ventures IV, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/24/2018
6:42 PM | Crispr Therapeutics (Issuer)
Woiwode Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/24/2018
6:41 PM | Bolzon Bradley J PhD (Reporting)
Crispr Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2018
3:50 PM | Crispr Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2018
3:49 PM | Crispr Therapeutics (Filer)
| Form DEFA14A
| |
04/18/2018
3:44 PM | Crispr Therapeutics (Filer)
| Form DEF 14A
| |
